247 related articles for article (PubMed ID: 27626779)
1. Targeted therapy: An elusive cancer target.
Brown C
Nature; 2016 Sep; 537(7620):S106-8. PubMed ID: 27626779
[No Abstract] [Full Text] [Related]
2. Perspective: What next for treatment?
Motzer RJ
Nature; 2016 Sep; 537(7620):S111. PubMed ID: 27626781
[No Abstract] [Full Text] [Related]
3. Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
Gao X; McDermott DF; Michaelson MD
Oncologist; 2019 Jun; 24(6):725-727. PubMed ID: 31036769
[TBL] [Abstract][Full Text] [Related]
4. Interview with professor Per-Anders Abrahamson: angiogenesis and renal cell carcinoma.
Abrahamson PA
Eur Urol; 2006 Sep; 50(3):609-11. PubMed ID: 16824676
[No Abstract] [Full Text] [Related]
5. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer BG; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
Urologe A; 2007 Sep; 46(9):1289-90. PubMed ID: 17624513
[No Abstract] [Full Text] [Related]
6. [Renal cell carcinoma: the end of a tunnel?].
Ravaud A; Dilhuydy MS
Pathol Biol (Paris); 2006 May; 54(4):206-8. PubMed ID: 16530346
[No Abstract] [Full Text] [Related]
7. Current overview of angiogenesis inhibitors.
Ellis LM
Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
[No Abstract] [Full Text] [Related]
8. Evolving role of novel targeted agents in renal cell carcinoma.
Hutson TE; Figlin RA
Oncology (Williston Park); 2007 Sep; 21(10):1175-80; discussion 1184, 1187, 1190. PubMed ID: 17926797
[TBL] [Abstract][Full Text] [Related]
9. [Targeted therapy for renal cell carcinoma].
Terai K; Horie S
Nihon Jinzo Gakkai Shi; 2016; 58(4):568-72. PubMed ID: 27416700
[No Abstract] [Full Text] [Related]
10. Impact of anti-angiogenic treatments on metastatic renal cell carcinoma.
Ainsworth NL; Lee JS; Eisen T
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1793-805. PubMed ID: 19954291
[TBL] [Abstract][Full Text] [Related]
11. Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: a critical review.
Porta C; Szczylik C; Escudier B
Crit Rev Oncol Hematol; 2012 Jun; 82(3):323-37. PubMed ID: 21733715
[TBL] [Abstract][Full Text] [Related]
12. From theoretical synergy to clinical supra-additive toxicity.
Soria JC; Massard C; Izzedine H
J Clin Oncol; 2009 Mar; 27(9):1359-61. PubMed ID: 19224836
[No Abstract] [Full Text] [Related]
13. Mutations in renal cell carcinoma.
D'Avella C; Abbosh P; Pal SK; Geynisman DM
Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
[TBL] [Abstract][Full Text] [Related]
14. What advances have been made in immune-therapy for renal cell carcinoma?
Verzoni E; Grassi P; Ratta R
Future Oncol; 2017 Apr; 13(8):665-668. PubMed ID: 28183189
[No Abstract] [Full Text] [Related]
15. [Effect of angiogenesis inhibitors on renal cell carcinoma].
Bodrogi I
Magy Onkol; 2007; 51(2):145-53. PubMed ID: 17660871
[TBL] [Abstract][Full Text] [Related]
16. Strategies to overcome therapeutic resistance in renal cell carcinoma.
Siska PJ; Beckermann KE; Rathmell WK; Haake SM
Urol Oncol; 2017 Mar; 35(3):102-110. PubMed ID: 28089416
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapies for kidney cancer in urologic practice.
Haas NB; Uzzo RG
Urol Oncol; 2007; 25(5):420-32. PubMed ID: 17826664
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic therapy in renal cell cancer.
Srinivasan R; Armstrong AJ; Dahut W; George DJ
BJU Int; 2007 May; 99(5 Pt B):1296-300. PubMed ID: 17441927
[TBL] [Abstract][Full Text] [Related]
19. [Novelties in the treatment for advanced renal-cell cancer].
Maráz A
Orv Hetil; 2011 Apr; 152(17):655-62. PubMed ID: 21464023
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for renal cell cancer: what are possible options?
Santos N; Wenger JB; Havre P; Liu Y; Dagan R; Imanirad I; Ivey AM; Zlotecki RA; Algood CB; Gilbert SM; Allegra CJ; Okunieff P; Vieweg J; Dang NH; Luesch H; Dang LH
Oncology; 2011; 81(3-4):220-9. PubMed ID: 22085914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]